Life
Maryland's Affordability Board Takes Action on Diabetes Medication Pricing
In a significant move, Maryland's State Affordability Board has initiated a process to establish a price cap for Jardiance, a medication for type 2 diabetes, with a target date set for January 2027.
editorial-staff
1 min read
Updated about 8 hours ago
Summary
The Maryland State Affordability Board has announced its first price cap on a medication, specifically targeting Jardiance, which is used to treat type 2 diabetes.
This decision marks a pivotal step in the board's efforts to manage and reduce medication costs for residents.
The board aims to implement this price cap by January 2027, although the specific details of the pricing process remain to be fully outlined.
Updates
- No subsequent updates recorded.